SG11201504779YA - Methods and compositions relating to treatment of cancer - Google Patents

Methods and compositions relating to treatment of cancer

Info

Publication number
SG11201504779YA
SG11201504779YA SG11201504779YA SG11201504779YA SG11201504779YA SG 11201504779Y A SG11201504779Y A SG 11201504779YA SG 11201504779Y A SG11201504779Y A SG 11201504779YA SG 11201504779Y A SG11201504779Y A SG 11201504779YA SG 11201504779Y A SG11201504779Y A SG 11201504779YA
Authority
SG
Singapore
Prior art keywords
cancer
treatment
methods
compositions relating
relating
Prior art date
Application number
SG11201504779YA
Other languages
English (en)
Inventor
Joshua E Allen
Wafik S El-Deiry
Arun K Sharma
Shantu G Amin
Rosalyn Irby
Original Assignee
Penn State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Penn State Res Found filed Critical Penn State Res Found
Publication of SG11201504779YA publication Critical patent/SG11201504779YA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG11201504779YA 2012-12-20 2013-12-20 Methods and compositions relating to treatment of cancer SG11201504779YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261740126P 2012-12-20 2012-12-20
PCT/US2013/076869 WO2014100565A1 (en) 2012-12-20 2013-12-20 Methods and compositions relating to treatment of cancer

Publications (1)

Publication Number Publication Date
SG11201504779YA true SG11201504779YA (en) 2015-07-30

Family

ID=49950064

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201504779YA SG11201504779YA (en) 2012-12-20 2013-12-20 Methods and compositions relating to treatment of cancer

Country Status (10)

Country Link
US (1) US20150328310A1 (enExample)
EP (1) EP2934583A1 (enExample)
JP (1) JP2016503063A (enExample)
KR (1) KR20150099588A (enExample)
CN (1) CN105007940B (enExample)
AU (1) AU2013361164A1 (enExample)
CA (1) CA2894547A1 (enExample)
RU (1) RU2015129366A (enExample)
SG (1) SG11201504779YA (enExample)
WO (1) WO2014100565A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL263815B (en) 2016-06-29 2022-07-01 Principia Biopharma Inc Modified release formulations of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[4,3-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4 -Methyl-4-[4-(Oxtan-3-yl)piperazin-1-yl)pent-2-ananitrile
AU2020365951B2 (en) 2019-10-14 2026-07-16 Principia Biopharma Inc. Methods for treating immune thrombocytopenia by administering (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile
KR102993352B1 (ko) 2019-12-20 2026-07-22 프린시피아 바이오파마, 인코퍼레이티드 2-[3-[4-아미노-3-(2-플루오로-4-페녹시-페닐)피라졸로[3,4-d]피리미딘-1-일]피페리딘-1-카르보닐]-4-메틸-4-[4-(옥세탄-3-일)피페라진-1-일]펜트-2-에네니트릴의 고체 형태
WO2021150723A1 (en) 2020-01-22 2021-07-29 Principia Biopharma Inc. Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)-1h-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9407386D0 (en) 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
US5648097A (en) 1995-10-04 1997-07-15 Biotek, Inc. Calcium mineral-based microparticles and method for the production thereof
US6391336B1 (en) 1997-09-22 2002-05-21 Royer Biomedical, Inc. Inorganic-polymer complexes for the controlled release of compounds including medicinals
WO2008128189A1 (en) * 2007-04-13 2008-10-23 The Penn State Research Foundation Anti-cancer compositions and methods

Also Published As

Publication number Publication date
RU2015129366A (ru) 2017-01-25
KR20150099588A (ko) 2015-08-31
CN105007940A (zh) 2015-10-28
AU2013361164A1 (en) 2015-07-02
WO2014100565A1 (en) 2014-06-26
EP2934583A1 (en) 2015-10-28
CA2894547A1 (en) 2014-06-26
US20150328310A1 (en) 2015-11-19
CN105007940B (zh) 2017-08-25
JP2016503063A (ja) 2016-02-01

Similar Documents

Publication Publication Date Title
IL288181A (en) Cancer treatment methods
EP2831001A4 (en) COMPOSITION FOR THE TREATMENT OF WATER AND METHOD FOR USE
IL234678A0 (en) Diagnostic methods and preparations for cancer treatment
IL238177A0 (en) Methods and preparations for the treatment of cancer
EP2771030A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF PROTEINOPATHIES
IL230770A0 (en) Methods and preparations related to p-62 for the treatment and prevention of cancer
DK3292875T3 (en) Compositions and methods for treating diseases
SG11201501381PA (en) Topical compositions and methods of use
EP2903644A4 (en) TREATMENT OF CANCER
SG11201504300VA (en) Accelerated prediction of cancer progression and response to treatment
ZA201503979B (en) Treatment of diseases involving mucin
IL235968A0 (en) Polysaccharide preparations and methods of use
IL234606A0 (en) Innovative methods and compounds for the treatment of diseases
GB201217892D0 (en) Treatment of cancer
PL2892556T3 (pl) Kompozycje i sposoby odnoszące się do leczenia chorób
IL233961B (en) The composition of a phytogenic supplement and methods of its use
GB201402983D0 (en) Compositions and methods for treatment of metastatic cancer
ZA201408057B (en) Compositions and methods for the treatment of moderate to severe pain
SG11201405279TA (en) Composition for enhancing defenses of skin
ZA201506392B (en) Compositions and methods including celecoxib and plumbagin relating to treatment of cancer
SG11201503270UA (en) Use of pidotimod to treat psoriasis
PL3079684T3 (pl) Kompozycje i sposoby do leczenia chorób związanych z układem renina-angiotensyna
GB201217890D0 (en) Treatment of cancer
GB201208296D0 (en) Treatment of cancer
AU2012902296A0 (en) Compositions for Therapy and Methods of Treatment